E N D
Supplementary Figure 1 Illustrating examples about the discrimination between neoplastic and normal residual B-cells contained in the CD19+ B-cell gate of a bone marrow sample from a follicular lymphoma patient (case 1: panels A to D); and a peripheral blood sample from a mantle cell lymphoma (case 2; panels E to H) Case 1: B C D A CD23 PE SSC-Exp CD10 PE SSC-Exp cyBCL2 FITC CD22 FITC CD19 PerCP-Cy5.5 FSC Case 2: E H G F SSC-Exp SSC-Ecp KAPPA PE CD19 PERCPCY5.5 FSC CD19 PERCP-Cy5.5 CD5 APC LAMBDA FITC